Financhill
Sell
43

LLYVA Quote, Financials, Valuation and Earnings

Last price:
$65.06
Seasonality move :
-15.33%
Day range:
$64.54 - $66.27
52-week range:
$32.55 - $79.63
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
427.2K
Avg. volume:
166K
1-year change:
54.7%
Market cap:
$6B
Revenue:
--
EPS (TTM):
-$0.33
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $11M $11M
Other Inc / (Exp) -- -- -- -$159M -$1M
Operating Expenses -- -- -- $11M $11M
Operating Income -- -- -- -$11M -$11M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$180M -$41M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -$38M -$8M
Net Income to Company -- -- -- -$142M -$33M
 
Minority Interest in Earnings -- -- -- -- $2M
Net Income to Common Excl Extra Items -- -- -- -$142M -$31M
 
Basic EPS (Cont. Ops) -- -- -- -$1.55 -$0.34
Diluted EPS (Cont. Ops) -- -- -- -$1.55 -$0.34
Weighted Average Basic Share -- -- -- $91.7M $91.8M
Weighted Average Diluted Share -- -- -- $91.7M $91.8M
 
EBITDA -- -- -- -$170M -$12M
EBIT -- -- -- -$170M -$12M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$11M -$11M
Operating Income (Adjusted) -- -- -- -$170M -$12M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $6M $4M
Other Inc / (Exp) -- -- -- -$142M -$127M
Operating Expenses -- -- -- $6M $4M
Operating Income -- -- -- -$6M -$4M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$156M -$138M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -$33M -$29M
Net Income to Company -- -- -- -- -$109M
 
Minority Interest in Earnings -- -- -- -- $2M
Net Income to Common Excl Extra Items -- -- -- -$123M -$107M
 
Basic EPS (Cont. Ops) -- -- -- -$1.34 -$1.17
Diluted EPS (Cont. Ops) -- -- -- -$1.34 -$1.17
Weighted Average Basic Share -- -- -- $91.7M $91.8M
Weighted Average Diluted Share -- -- -- $91.7M $91.8M
 
EBITDA -- -- -- -$148M -$131M
EBIT -- -- -- -$148M -$131M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$6M -$4M
Operating Income (Adjusted) -- -- -- -$148M -$131M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- $11M
Other Inc / (Exp) -- -- -- -$159M -$1M
Operating Expenses -- -- -- -- $11M
Operating Income -- -- -- -- -$11M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- -$41M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- -$8M
Net Income to Company -- -- -- -- -$33M
 
Minority Interest in Earnings -- -- -- -- $2M
Net Income to Common Excl Extra Items -- -- -- -- -$31M
 
Basic EPS (Cont. Ops) -- -- -- -- -$0.33
Diluted EPS (Cont. Ops) -- -- -- -- -$0.33
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- -$12M
EBIT -- -- -- -- -$12M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- -$11M
Operating Income (Adjusted) -- -- -- -- -$12M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- $11M $11M --
Other Inc / (Exp) -- -- -$159M -$1M --
Operating Expenses -- -- $11M $11M --
Operating Income -- -- -$11M -$11M --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -$180M -$41M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -$38M -$8M --
Net Income to Company -- -- -- -$33M --
 
Minority Interest in Earnings -- -- -- $2M --
Net Income to Common Excl Extra Items -- -- -$142M -$31M --
 
Basic EPS (Cont. Ops) -- -- -$1.55 -$0.33 --
Diluted EPS (Cont. Ops) -- -- -$1.55 -$0.33 --
Weighted Average Basic Share -- -- $183.4M $367.6M --
Weighted Average Diluted Share -- -- $183.4M $367.6M --
 
EBITDA -- -- -$170M -$12M --
EBIT -- -- -$170M -$12M --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -$11M -$11M --
Operating Income (Adjusted) -- -- -$170M -$12M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents -- -- -- $305M $325M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $305M $325M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- $333M $458M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- $357M $223M
Total Assets -- -- -- $1.2B $1.2B
 
Accounts Payable -- -- -- $2M $3M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- $70M --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- $8M --
Total Current Liabilities -- -- -- $80M $3M
 
Long-Term Debt -- -- -- $1.2B $1.6B
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $1.3B $1.6B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -$188M -$359M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- $23M $22M
Total Equity -- -- -- -$165M -$337M
 
Total Liabilities and Equity -- -- -- $1.2B $1.2B
Cash and Short Terms -- -- -- $305M $325M
Total Debt -- -- -- -- --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents -- -- -- $305M $325M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $305M $325M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- $333M $458M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- $357M $223M
Total Assets -- -- -- $1.2B $1.2B
 
Accounts Payable -- -- -- $2M $3M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- $70M --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- $8M --
Total Current Liabilities -- -- -- $80M $3M
 
Long-Term Debt -- -- -- $1.2B $1.6B
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $1.3B $1.6B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- $23M $22M
Total Equity -- -- -- -$165M -$337M
 
Total Liabilities and Equity -- -- -- $1.2B $1.2B
Cash and Short Terms -- -- -- $305M $325M
Total Debt -- -- -- -- --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -- -- -- -$142M -$33M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- $2M $4M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$13M -$14M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -$3M -$3M
Cash From Investing -- -- -- $1.1B $105M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- $1.1B --
Long-Term Debt Repaid -- -- -- -$918M -$71M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $100M --
Cash From Financing -- -- -- $317M -$71M
 
Beginning Cash (CF) -- -- -- -- $305M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $305M $19M
Ending Cash (CF) -- -- -- $305M $325M
 
Levered Free Cash Flow -- -- -- -$13M -$14M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -- -- -- -- -$109M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- $1M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- -$3M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- -$107M
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- -$59M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$1M
Cash From Financing -- -- -- -- -$60M
 
Beginning Cash (CF) -- -- -- -- $388M
Foreign Exchange Rate Adjustment -- -- -- -- $1M
Additions / Reductions -- -- -- -- -$64M
Ending Cash (CF) -- -- -- -- $325M
 
Levered Free Cash Flow -- -- -- -- -$3M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -- -- -- -- -$33M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- $4M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- -$14M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- -$3M
Cash From Investing -- -- -- -- $105M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- -$71M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- -$71M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $19M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- -$14M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -- -- -- -$33M --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- $4M --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$14M --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -$3M --
Cash From Investing -- -- -- $105M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$71M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -$71M --
 
Beginning Cash (CF) -- -- -- $1.4B --
Foreign Exchange Rate Adjustment -- -- -- $1M --
Additions / Reductions -- -- -- $19M --
Ending Cash (CF) -- -- -- $1.4B --
 
Levered Free Cash Flow -- -- -- -$14M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tenable Stock a Buy, Sell or Hold?
Is Tenable Stock a Buy, Sell or Hold?

Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 24

Regencell Bioscience Holdings [RGC] is down 17.76% over the past day.

Sell
36
VMI alert for Mar 24

Valmont Industries [VMI] is up 3.82% over the past day.

Buy
61
ALNY alert for Mar 24

Alnylam Pharmaceuticals [ALNY] is up 5.26% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock